Propofol-based sedation does not negatively influence oxygenator running time compared to midazolam in patients with extracorporeal membrane oxygenation

Abstract

Objective:

Patients on extracorporeal membrane oxygenation are frequently in need for sedation. Use of propofol has been associated with impaired oxygenator function due to adsorption to the membrane as well as lipid load. The aim of our retrospective analysis was to compare two different sedation regimens containing either propofol or midazolam with respect to oxygenator running time.

Methods:

Midazolam was used in 73 patients whereas propofol was used in 49 patients, respectively. In the propofol group, veno-arterial–extracorporeal membrane oxygenation was used predominantly (84%), while veno-venous–extracorporeal membrane oxygenation was used more often in the midazolam group (64%).

Results:

Oxygenator running time until first exchange was 7 days in both groups (p = 0.759). No statistically significant differences could be observed between the subgroup of patients receiving lipid-free (n = 24) and lipid-containing (n = 31) parenteral nutrition, respectively. Laboratory parameters like triglycerides, free hemoglobin, fibrinogen, platelets, and activated partial thromboplastin time were not significantly different between both sedation regimens (p = 0.462, p = 0.489, p = 0.960, p = 0.134, and p = 0.843) and were not associated with oxygenator running time.

Conclusion:

The use of propofol as sedative seems suitable in patients undergoing extracorporeal membrane oxygenation therapy.

Keywords

Sedation midazolam propofol extracorporeal membrane oxygenation oxygenator running time

Get full access to this article

View all access options for this article.

References

Thiagarajan

Barbaro

Rycus

et al . Extracorporeal Life Support Organization Registry International Report 2016. ASAIO J 2017; 63: 60–67.

Bartlett

RH.

Extracorporeal life support: history and new directions. ASAIO J 2005; 51: 487–489.

Long

Hei

et al . Clinical evaluation of two different extracorporeal membrane oxygenation systems: a single center report. Artif Organs 2011; 35(7): 733–737.

Lubnow

Philipp

Foltan

et al . Technical complications during veno-venous extracorporeal membrane oxygenation and their relevance predicting a system-exchange—retrospective analysis of 265 cases. PLoS ONE 2014; 9(12): e112316.

Jacobi

Fraser

Coursin

et al . Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30: 119–141.

Harthan

Buckley

Heger

et al . Medication adsorption into contemporary extracorporeal membrane oxygenator circuits. J Pediatr Pharmacol Ther 2014; 19(4): 288–295.

Lopez

Kosk-Kosicka

Entropy-driven interactions of anesthetics with membrane proteins. Biochemistry 1997; 36(29): 8864–8872.

Myers

Voorhees

Eke

et al . The effect of Diprivan (propofol) on phosphorylcholine surfaces during cardiopulmonary bypass—an in vitro investigation. Perfusion 2009; 24(5): 349–355.

Hohlfelder

Szumita

Lagambina

et al . Safety of propofol for oxygenator exchange in extracorporeal membrane oxygenation. ASAIO J 2017; 63(2): 179–184.

10.

Jacqz-Aigrain

Daoud

Burtin

et al . Pharmacokinetics of midazolam during continuous infusion in critically ill neonates. Eur J Clin Pharmacol 1992; 42(3): 329–332.

11.

Devlin

Roberts

RJ.

Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Crit Care Clin 2009; 25: 431–449, vii.

12.

Extracorporeal Life Support Organization. ELSO Anticoagulation Guideline. Ann Arbor, MI, 2014, https://www.elso.org/portals/0/files/elsoanticoagulationguideline8-2014-table-contents.pdf (accessed 12 November 2018).

13.

Nigoghossian

Dzierba

Etheridge

et al . Effect of extracorporeal membrane oxygenation use on sedative requirements in patients with severe acute respiratory distress syndrome. Pharmacotherapy 2016; 36(6): 607–616.

14.

Shekar

Roberts

Welch

et al . ASAP ECMO: antibiotic, sedative and analgesic pharmacokinetics during extracorporeal membrane oxygenation: a multi-centre study to optimise drug therapy during ECMO. BMC Anesthesiol 2012; 12: 29.

15.

Cheng

Abdul-Aziz

Roberts

et al . Optimising drug dosing in patients receiving extracorporeal membrane oxygenation. J Thorac Dis 2018; 10(Suppl. 5): S629–S641.

16.

Eddleston

Shelly

MP.

The effect on serum lipid concentrations of a prolonged infusion of propofol–hypertriglyceridaemia associated with propofol administration. Intensive Care Med 1991; 17(7): 424–426.

17.

Lee

Archer

Dargan

et al . What are the adverse effects associated with the combined use of intravenous lipid emulsion and extracorporeal membrane oxygenation in the poisoned patient. Clin Toxicol 2015; 53(3): 145–150.

18.

Kadri

Rhee

Strich

et al . Estimating ten-year trends in septic shock incidence and mortality in United States Academic Medical Centers using clinical data. Chest 2017; 151(2): 278–285.

19.

deBacker

Tamberg

Munshi

et al . Sedation practice in extracorporeal membrane oxygenation-treated patients with acute respiratory distress syndrome: a retrospective study. ASAIO J 2018; 64: 544–551.

20.

Lonardo

Mone

Nirula

et al . Propofol is associated with favorable outcomes compared with benzodiazepines in ventilated intensive care unit patients. Am J Respir Crit Care Med 2014; 189(11): 1383–1394.

21.

Constantin

Momon

Mantz

et al . Efficacy and safety of sedation with dexmedetomidine in critical care patients: a meta-analysis of randomized controlled trials. Anaesth Crit Care Pain Med 2016; 35(1): 7–15.

22.

Verkoyen

Schildhauer

Strauch

et al . The effects of propofol and isoflurane sedation on the outcomes of surgical patients receiving extracorporeal membrane oxygenation. ASAIO J 2017; 63(2): 174–178.

23.

Umezawa Makikado

Flordelis Lasierra

Perez-Vela

et al . Early enteral nutrition in adults receiving venoarterial extracorporeal membrane oxygenation: an observational case series. JPEN J Parenter Enteral Nutr 2013; 37(2): 281–284.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB